Clinical trial
A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus…
NCT00481702 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00481702 |
|---|---|
| Title | A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802) |
| Official title | A Prospective, Multicenter, Open-Label, Randomized, Comparative Study to Evaluate the Efficacy, Safety, and Tolerability of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-Abdominal Infections in Adults |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Intra-abdominal Infection |
| Intervention type | Drug |
| Interventions | Comparator: ceftriaxone sodium / Duration of Treatment: 8 Weeks, MK0826, /Duration of Treatment : 8 Weeks, Comparator: metronidazole / Duration of Treatment: 8 Weeks |
| Enrollment | 300 |
| Start date | Dec 1, 2001 |
| Primary completion | Jun 1, 2003 |
| Completion | Jun 1, 2003 |
| First posted | Jun 4, 2007 |
| Last update posted | Feb 20, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: